Topic starter
02/08/2026 11:48 am
TL;DR: Most Annex III systems use internal control, while biometric cases and systems without harmonized standards need notified body review, Openlayer reports. That choice sets the evidence burden, scheduling pace, and how early documentation and monitoring must be in place.
Editorial analysis by NHI Mgmt Group, based on content published by Openlayer: “EU AI Act Conformity Assessment Guide April 2026”.
Key questions
Q: Why does choosing the wrong conformity path create compliance risk?
A: Because each path expects different timing and evidence maturity.
Q: What breaks when technical documentation is incomplete for EU AI Act conformity assessment?
A: Incomplete documentation stalls self-assessment and can fail a notified body review.
Q: How should teams decide whether an AI system needs internal control or notified body review?
A: Start by classifying the system against the EU AI Act's high-risk categories.
Practitioner guidance
- Map the assessment route at intake Classify each high-risk AI system against Annex I and Annex III before design decisions harden, so the programme knows whether internal control or notified body review applies.
- Build the QMS before deployment Document risk management, data governance, testing, version control, and post-market monitoring as live controls, not retroactive artefacts.
- Treat technical documentation as evidence engineering Maintain system description, training data provenance, performance results, limitations, and test records as one controlled evidence set.
Bottom line: The core risk in EU AI Act conformity assessment is not just meeting the deadline, but selecting the wrong review path early enough to derail evidence building.
Glossary terms: Conformity assessment, Internal Control Procedure, Notified Body, Quality Management System
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
This topic was modified 2 days ago by NHI Mgmt Group
02/08/2026 12:58 pm
Path selection is now a governance control, not an administrative detail. The article shows that the real compliance failure mode is choosing the assessment route too late, after documentation and monitoring design are already locked in. That means AI governance teams need the conformity pathway decided at project inception, because the route determines which evidence must exist and who must validate it.
A few things that frame the scale:
- 92% of organisations expose NHIs to third parties, raising concerns about supply chain security, according to the Ultimate Guide to NHIs.
A question worth separating out:
A: Treat it as part of the same control loop. The EU AI Act expects ongoing evidence that the system continues to perform as assessed, so logging, performance tracking, and feedback into risk management must survive deployment. If monitoring sits outside the release process, the organisation loses continuity between approval and operation.
👉 Read our full editorial: EU AI Act conformity assessment hinges on the right path